Fibrinolysis and the control of blood coagulation.
Chapin JC, Hajjar KA.
Blood Rev. 2015 Jan;29(1):17-24. doi: 10.1016/j.blre.2014.09.003. Epub 2014 Sep 16.
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators.
N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9.
Disorders of Fibrinogen and Fibrinolysis.
May JE, Wolberg AS, Lim MY.
Hematol Oncol Clin North Am. 2021 Dec;35(6):1197-1217. doi: 10.1016/j.hoc.2021.07.011. Epub 2021 Aug 14.
A review of hyperfibrinolysis in cats and dogs.
Birkbeck R, Humm K, Cortellini S.
J Small Anim Pract. 2019 Nov;60(11):641-655. doi: 10.1111/jsap.13068. Epub 2019 Oct 13.
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators.
N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533.
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease.
Payne RM, Burns KM, Glatz AC, Male C, Donti A, Brandão LR, Balling G, VanderPluym CJ, Bu'Lock F, Kochilas LK, Stiller B, Cnota JF 2nd, Rahkonen O, Khan A, Adorisio R, Stoica S, May L, Burns JC, Saraiva JFK, McHugh KE, Kim JS, Rubio A, Chía-Vazquez NG, Meador MR, Dyme JL, Reedy AM, Ajavon-Hartmann T, Jarugula P, Carlson-Taneja LE, Mills D, Wheaton O, Monagle P.
J Am Coll Cardiol. 2023 Dec 12;82(24):2296-2309. doi: 10.1016/j.jacc.2023.10.010.
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer.
Falanga A, Leader A, Ambaglio C, Bagoly Z, Castaman G, Elalamy I, Lecumberri R, Niessner A, Pabinger I, Szmit S, Trinchero A, Ten Cate H, Rocca B.
Hemasphere. 2022 Jul 13;6(8):e750. doi: 10.1097/HS9.0000000000000750. eCollection 2022 Aug.
Temporal Changes in Fibrinolysis following Injury.
Moore HB, Moore EE.
Semin Thromb Hemost. 2020 Mar;46(2):189-198. doi: 10.1055/s-0039-1701016. Epub 2020 Mar 11.
Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients.
Gurvits GE, Fradkov E.
World J Gastroenterol. 2017 Jun 14;23(22):3945-3953. doi: 10.3748/wjg.v23.i22.3945.
Caplacizumab: First Global Approval.
Duggan S.
Drugs. 2018 Oct;78(15):1639-1642. doi: 10.1007/s40265-018-0989-0.
